These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 6172668)

  • 1. Long-term treatment of hypertension with methyldopa. VIII. Overview.
    Itskovitz HD
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S120-7. PubMed ID: 6172668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of Hypertension with methyldopa. II. Therapeutic efficacy.
    Fitz AE; Saunders E
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S85-91. PubMed ID: 6172671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of hypertension with methyldopa. III. Tolerability.
    Caldwell JR; Metts JC
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S92-8. PubMed ID: 6172672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term treatment of hypertension with methyldopa. I. Study objectives and design.
    Itskovitz HD; Menduke H
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S79-84. PubMed ID: 6172670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of hypertension with methyldopa. IV. Duration of methyldopa therapy.
    del Greco F; Huang CM; Quintanilla A
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S99-103. PubMed ID: 6172673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term treatment of hypertensive with methyldopa. VI. Patient with target organ disease.
    Brest AN
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S109-13. PubMed ID: 6172666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment of hypertension with methyldopa. A retrospective multiclinic study.
    J Cardiovasc Pharmacol; 1981; 3 Suppl 2():S75-127. PubMed ID: 6172669
    [No Abstract]   [Full Text] [Related]  

  • 8. Methyldopa: single daily dose versus multiple daily dose.
    Yang C; Gurwich E; Kanada S; Nascimento L
    Clin Ther; 1982; 4(5):395-401. PubMed ID: 7039841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.
    Janssens M; Symoens J
    J Hypertens Suppl; 1986 Dec; 4(6):S115-8. PubMed ID: 3302148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of metoprolol and methyldopa in the treatment of hypertension.
    Karachalios GN
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):476-8. PubMed ID: 6629553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the antihypertensive action of methyldopa alone or in combination with hydrochlorothiazide].
    Mattar E; Cruz HM; Cruz J
    Rev Paul Med; 1971 Jul; 78(1):19-30. PubMed ID: 5164628
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiclinic evaluation of the antihypertensive effect of a methyldopa, hydrochlorothiazine, and amiloride combination.
    Moncloa F; Hwang IK; Muccilli AC
    Clin Ther; 1980; 3(3):168-75. PubMed ID: 7006811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Al-Damluji SF; Al-Khalidi A; Shaarbaf H; Tawfiq NH
    Pharmatherapeutica; 1982; 3(2):133-9. PubMed ID: 7048338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metolazone in essential hypertension: the long-term clinical efficacy of a new diuretic.
    Dornfeld L; Kane RE
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):527-33. PubMed ID: 810314
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of guanethidine and methyldopa in essential hypertension: a controlled study.
    Glazer N
    Curr Ther Res Clin Exp; 1975 Mar; 17(3):249-56. PubMed ID: 805019
    [No Abstract]   [Full Text] [Related]  

  • 17. Methyldopa: an agent for the treatment of older patients with isolated systolic hypertension.
    Vaicaitis JS
    Clin Ther; 1984; 6(4):451-6. PubMed ID: 6467278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy of alpha-methyldopa, chlorothiazide and Supres-150 (alpha-methyldopa-chlorothiazide).
    Fernandez PG; Zachariah PK; Bryant DG; Missan SS
    Can Med Assoc J; 1980 Aug; 123(4):284-7. PubMed ID: 7020900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alprenolol and alphamethyl-dopa in untreated cases of essential hypertension--a comparison].
    Bergstrand RH; Vedin JA; Wilhelmsson CE
    Lakartidningen; 1973 Aug; 70(33):2817-20. PubMed ID: 4597664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.